COCH Graph | ENVOY MEDICAL, INC.

COCH Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

2026-06-30: Revenue $51.00K; Cost of revenue $278.00K; Research and development $3.13M; Selling, general and administrative (m).
2026-03-31: Revenue $39.00K; Cost of revenue $313.00K; Research and development $3.64M; Selling, general and administrative (m).
2025-09-30: Revenue $42.00K; Cost of revenue $203.00K; Research and development $2.70M; Selling, general and administrative (m).
2025-06-30: Revenue $78.00K; Cost of revenue $234.00K; Research and development $2.48M; Selling, general and administrative (m).

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Income tax	Net income
2026-06-30	$51.00K	$278.00K	$3.13M	(m)	(m)	-$5.98M
2026-03-31	$39.00K	$313.00K	$3.64M	(m)	(m)	-$4.35M
2025-09-30	$42.00K	$203.00K	$2.70M	(m)	(m)	-$6.48M
2025-06-30	$78.00K	$234.00K	$2.48M	(m)	(m)	-$5.69M
2025-03-31	$46.00K	$226.00K	$2.75M	(m)	(m)	-$5.00M
2024-09-30	$56.00K	$187.00K	$2.76M	(m)	(m)	-$5.96M
2024-06-30	$68.00K	$245.00K	$2.59M	(m)	(m)	-$3.95M
2024-03-31	$59.00K	$153.00K	$2.36M	(m)	(m)	-$6.27M
2023-12-31	(m)	(m)	(m)	$1.88M*	(m)	(m)
2023-09-30	$80.00K	$189.00K	$1.85M	$1.43M	(m)	$1.56M
2023-06-30	$63.00K	$162.00K	$2.15M	(m)	$121.25K	-$13.34M
2023-03-31	$78.00K	$175.00K	$1.93M	(m)	$841.52K	-$13.25M
2022-12-31	(m)	(m)	(m)	(m)	$859.44K*	(m)
2022-09-30	$57.00K	$106.00K	$935.00K	$812.00K	$533.96K	-$1.34M
2022-06-30	(m)	(m)	(m)	(m)	$108.31K	-$1.24M
2022-03-31	(m)	(m)	(m)	(m)	$0.00	-$1.87M
2021-09-30	(m)	(m)	(m)	(m)	$0.00	$5.57M
2021-06-30	(m)	(m)	(m)	(m)	$0.00	$371.14K
2021-03-31	(m)	(m)	(m)	(m)	(m)	-$1.47M

Revenue and expense 6 month

Period end	Revenue	Cost of revenue	Research and development	Income tax	Net income
2026-06-30	$90.00K	$591.00K	$6.77M	(m)	-$10.33M
2025-06-30	$124.00K	$460.00K	$5.23M	(m)	-$10.69M
2024-06-30	$127.00K	$398.00K	$4.95M	(m)	-$10.22M
2023-06-30	$141.00K	$337.00K	$4.08M	$962.77K	-$26.50M
2022-06-30	(m)	(m)	(m)	$108.31K	$15.55M
2021-06-30	(m)	(m)	(m)	$0.00	-$1.10M

Revenue and expense 9 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Income tax	Net income
2025-09-30	$166.00K	$663.00K	$7.93M	(m)	(m)	-$17.17M
2024-09-30	$183.00K	$585.00K	$7.71M	(m)	(m)	-$16.18M
2023-09-30	$221.00K	$555.00K	$5.90M	$5.40M	(m)	-$25.03M
2022-09-30	$217.00K	$347.00K	$3.53M	$2.14M	$642.27K	-$4.45M
2021-09-30	(m)	(m)	(m)	(m)	$0.00	$4.47M

Revenue and expense 12 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Income tax	Net income
2025-12-31	$241.00K	$874.00K	$12.49M	(m)	(m)	-$23.76M
2024-12-31	$225.00K	$742.00K	$10.18M	(m)	(m)	-$20.80M
2023-12-31	$316.00K	$789.00K	$8.96M	$7.28M	(m)	-$29.92M
2022-12-31	$237.00K	$498.00K	$4.97M	$2.58M	$1.50M	-$15.92M
2021-12-31	(m)	(m)	(m)	(m)	(m)	-$251.63K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ALPHA PRO TECH LTD (APT)		$0.052B	13.63
MYOMO, INC. (MYO)	United States	$0.065B	-2.85
MILESTONE SCIENTIFIC INC. (MLSS)	United States	$0.036B	-6.85
Safe Pro Group Inc. (SPAI)	United States	$0.090B
Lifeward Ltd. (LFWD)		$0.021B
ENvue Medical, Inc. (FEED)	United States	$0.011B
LAKELAND INDUSTRIES INC (LAKE)	United States	$0.104B	-4.21
NutriBand Inc. (NTRB)	United States	$0.109B
Bone Biologics Corp (BBLG)	United States	$0.001B
Conexeu Sciences Inc. (CNXU)	United States	$0.111B